FolioLanternBeta
REGNRegeneron Pharmaceuticals

George Sing

Director at Regeneron Pharmaceuticals, as of Jan 6, 2026No sales or purchases in the past 12 months.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
33K
shares held after the latest filing, Regeneron Pharmaceuticals
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
1
company filed for

Last filing: Jan 6, 2026. Most recent sale before this period: Feb 26, 2024. Most recent purchase on record: May 18, 2010.

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Regeneron Pharmaceuticals (REGN)DirectorJan 6, 2004Jan 6, 2026

Recent filings

The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.